Bessemer Group’s Option Care Health OPCH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$237K Sell
11,290
-9,236
-45% -$215K ﹤0.01% 1351
2026
Q1
$553K Buy
20,526
+19,597
+2,109% +$636K ﹤0.01% 1102
2025
Q4
$30K Buy
929
+56
+6% +$1.64K ﹤0.01% 1772
2025
Q3
$25K Sell
873
-774
-47% -$22.4K ﹤0.01% 1631
2025
Q2
$54K Buy
1,647
+87
+6% +$2.81K ﹤0.01% 1319
2025
Q1
$54K Buy
1,560
+599
+62% +$18.8K ﹤0.01% 1298
2024
Q4
$22K Sell
961
-2,266
-70% -$57.3K ﹤0.01% 1494
2024
Q3
$101K Buy
3,227
+302
+10% +$9.27K ﹤0.01% 1283
2024
Q2
$81K Buy
2,925
+779
+36% +$23.2K ﹤0.01% 1207
2024
Q1
$72K Sell
2,146
-38
-2% -$1.23K ﹤0.01% 1233
2023
Q4
$73K Sell
2,184
-136
-6% -$4.18K ﹤0.01% 1273
2023
Q3
$75K Buy
2,320
+122
+6% +$4.11K ﹤0.01% 1271
2023
Q2
$71K Sell
2,198
-253,949
-99% -$7.66M ﹤0.01% 1313
2023
Q1
$8.14M Buy
256,147
+394
+0.2% +$11.8K 0.02% 273
2022
Q4
$7.69M Buy
+255,753
New +$7.94M 0.02% 278

Other funds holding OPCH

Bessemer Group's OPCH Position: Q2 2026 in Review

Bessemer Group reduced its Option Care Health (OPCH) stake by 45% in Q2 2026, selling an estimated $215K and leaving 11,290 shares worth $237K. The position accounts for ﹤0.01% of the portfolio, ranked #1351.

Bessemer Group first reported a position in OPCH in Q4 2022 and has held it in 15 quarters since. The position peaked at $8.14M in Q1 2023. 373 funds tracked by Wall St. Rank hold OPCH as of Q2 2026.

  • Bessemer Group held 11,290 shares of Option Care Health worth $237K as of Q2 2026.
  • Bessemer Group sold 9,236 Option Care Health shares in Q2 2026, an estimated $215K.
  • Option Care Health made up ﹤0.01% of Bessemer Group's portfolio in Q2 2026, its #1351 holding.
  • Bessemer Group first reported a position in Option Care Health in Q4 2022 and has held it in 15 quarters since.
  • Bessemer Group's Option Care Health position peaked at $8.14M in Q1 2023.
  • 373 funds tracked by Wall St. Rank held Option Care Health as of Q2 2026.

Based on Bessemer Group's 13F filing for Q2 2026, filed 12 Aug 2026.